by Erik Kobayashi-Solomon | Jun 21, 2017 | Research
Globus Medical GMED is a small-capitalization orthopedic device manufacturer focused on ailments of the spine. Its slowing revenues are worrisome, and make us think that the downside valuation scenarios we have…
by Erik Kobayashi-Solomon | Jun 20, 2017 | Research
In addition to our Tear Sheet, our Five-Minute Valuation, and our earlier commentary on Kroger, here is our valuation model and the BSM Cone workbook after Amazon made the announcement it…
by Erik Kobayashi-Solomon | Jun 19, 2017 | Research
A client has a position in the preferred shares of AES Corporation (AES) – a utility with operations in various overseas markets in addition to a smaller exposure to the US…
by Erik Kobayashi-Solomon | Jun 16, 2017 | Research
With the announcement that Amazon was acquiring Whole Foods this morning, Kroger and other grocers’ stock prices are being pushed down. While yesterday’s drop was probably justified, today’s may not…
by Erik Kobayashi-Solomon | Jun 16, 2017 | Research
On February 24, we published a Tear Sheet suggesting what we call a “bearish diagonal” investment strategy using options on Union Pacific UNP. This strategy used two option legs –…
by Erik Kobayashi-Solomon | Jun 12, 2017 | Research
Last week, we did a Five-Minute Valuation of Bristol-Myers Squibb at the request of long-time reader Wilson M. Wilson, who is a Wall Street professional, wanted to go one step…
